Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Biological Chemistry|January 15, 2002
Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell lineTakashi Murate, Motoshi Suzuki, Masashi Hattori, et al.
Cancer Science|April 25, 2006
Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphomaMichinori Ogura, Yasuo Morishima, Yoshitoyo Kagami, et al.
International Journal of Hematology|August 5, 2003
Clinical effects of infusing anti-Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes into patients with severe chronic active EBV infectionMasao Hagihara, Takahide Tsuchiya, Osamu Hyodo, et al.
International Journal of Hematology|June 19, 2010
Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myelomaShinsuke Iida, Takaaki Chou, Shinichiro Okamoto, et al.
British Journal of Haematology|August 10, 2007
Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemiaRikio Suzuki, Makoto Onizuka, Minoru Kojima, et al.
Japanese Journal of Clinical Oncology|January 21, 2011
Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112Takaaki Chou, Kensei Tobinai, Naokuni Uike, et al.
Experimental Hematology|December 10, 2003
In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cellsYukari Muguruma, Morayma Reyes, Yoshihiko Nakamura, et al.
Japanese Journal of Clinical Oncology|March 5, 2013
Phase I study of ofatumumab, a human anti-CD20 antibody, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphomaMichinori Ogura, Kiyohiko Hatake, Kensei Tobinai, et al.
The Tokai Journal of Experimental and Clinical Medicine|September 9, 2005
Pulmonary non-caseating granuloma in Waldenström macroglobulinemiaRyuki Fukuda, Hiroshi Kawada, Yoshiaki Ogawa, et al.
Leukemia Research|May 14, 2011
A Phase I study to assess the safety, pharmacokinetics and efficacy of barasertib (AZD1152), an Aurora B kinase inhibitor, in Japanese patients with advanced acute myeloid leukemiaKosuke Tsuboi, Toshiya Yokozawa, Toru Sakura, et al.
Pageof 12